Mulsun Biotech Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 974

Employees

  • Latest Deal Type
  • IPO
  • (Announced)

  • Investors
  • 12

Mulsun Biotech General Information

Description

Developer of factory-based silkworm rearing technology and silk protein applications designed to modernize traditional sericulture through biotechnology and automation. The company integrates artificial feed formulas, intelligent equipment, and environmental control systems to produce fresh cocoons, dried cocoons, and silk floss, enabling the year-round stable production of high-quality silk materials and the development of silk protein for food preservation and cosmetics.

Contact Information

Website
www.lxm3s.com
Ownership Status
In IPO Registration
Financing Status
Venture Capital-Backed
Corporate Office
  • No. 788, Yijing Road, Sanjiang Street
  • Shengzhou
  • Shaoxing, Zhejiang 312400
  • China
+86 0575
Primary Industry
Animal Textiles
Corporate Office
  • No. 788, Yijing Road, Sanjiang Street
  • Shengzhou
  • Shaoxing, Zhejiang 312400
  • China
+86 0575

Mulsun Biotech Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mulsun Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. IPO 29-Jun-2026 Announced Profitable
13. IPO 22-Jan-2026 Completed Profitable
12. Secondary Transaction - Private 23-Oct-2025 Completed Profitable
11. Secondary Transaction - Private 08-Sep-2025 Completed Profitable
10. Later Stage VC 07-Aug-2025 Completed Profitable
9. Later Stage VC 01-Apr-2024 Completed Profitable
8. Later Stage VC (Series A2) 22-Dec-2023 Completed Profitable
7. Later Stage VC (Series A2) 15-Dec-2023 Completed Profitable
6. Later Stage VC (Series A1) 28-Jun-2023 $17.4M $51.5M Completed Profitable
5. Secondary Transaction - Private 24-May-2023 $23M $34.2M Completed Profitable
To view Mulsun Biotech’s complete valuation and funding history, request access »

Mulsun Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 8,183,300 $1.72 $1.72 1x $1.72 5.41%
Ordinary 4,484,300 $3.85 $3.85 1x $3.85 2.96%
To view Mulsun Biotech’s complete cap table history, request access »

Mulsun Biotech Patents

Mulsun Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026199424-A1 Composite silk fiber containing spider silk protein and preparation method therefor Pending 28-Mar-2025

Mulsun Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mulsun Biotech Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Moutai (Guizhou) Private Equity Fund Management Growth/Expansion Minority
SDIC Innovation Industry Fund Management Government Minority
China Merchants Capital Asset Manager Minority
Youngor Group Company Corporation Minority
Hangzhou Shengchuang Jiyue Private Equity Fund Management Growth/Expansion Minority
You’re viewing 5 of 12 investors. Get the full list »

Mulsun Biotech FAQs

  • When was Mulsun Biotech founded?

    Mulsun Biotech was founded in 2015.

  • Where is Mulsun Biotech headquartered?

    Mulsun Biotech is headquartered in Shaoxing, China.

  • What is the size of Mulsun Biotech?

    Mulsun Biotech has 974 total employees.

  • What industry is Mulsun Biotech in?

    Mulsun Biotech’s primary industry is Animal Textiles.

  • Is Mulsun Biotech a private or public company?

    Mulsun Biotech is a Private company.

  • What is Mulsun Biotech’s current revenue?

    The current revenue for Mulsun Biotech is .

  • How much funding has Mulsun Biotech raised over time?

    Mulsun Biotech has raised $112M.

  • Who are Mulsun Biotech’s investors?

    Moutai (Guizhou) Private Equity Fund Management, SDIC Innovation Industry Fund Management, China Merchants Capital, Youngor Group Company, and Hangzhou Shengchuang Jiyue Private Equity Fund Management are 5 of 12 investors who have invested in Mulsun Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process